Monia Brett P — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

Monia Brett P has filed 3 SEC Form 4 filings across 2 companies in the last 90 days — selling. Lifetime open-market sales: $43.06M.

Profile

Monia Brett P

Brett P. Monia is the Chief Executive Officer and Director of Ionis Pharmaceuticals, a leader in antisense technology for drug development. Under his leadership, Ionis has focused on innovative treatments for various diseases, including cardiovascular and neurological conditions.

RoleChief Executive Officer, Director
Notability50/100

Board memberships

Awards & honors

Recent Transactions

DateTickerCompanyCodeSharesPriceValue
2026-06-26IONSIONIS PHARMACEUTICALS INCS — Open-market sale50.0K$80.59$4.03M
2026-06-26IONSIONIS PHARMACEUTICALS INCM — Option exercise50.0K$56.78$2.84M
2026-06-26IONSIONIS PHARMACEUTICALS INCS — Open-market sale21.1K$78.49$1.65M
2026-06-26IONSIONIS PHARMACEUTICALS INCM — Option exercise21.1K$32.60$687K
2026-06-26IONSIONIS PHARMACEUTICALS INCS — Open-market sale14.6K$78.41$1.14M
2026-06-26IONSIONIS PHARMACEUTICALS INCM — Option exercise14.6K$32.60$475K
2026-06-22CGTXCOGNITION THERAPEUTICS INCA — Grant or award25.0K$0.00
2026-05-15IONSIONIS PHARMACEUTICALS INCS — Open-market sale3.2K$78.68$253K
2026-05-15IONSIONIS PHARMACEUTICALS INCM — Option exercise3.2K$32.60$105K
2026-05-15IONSIONIS PHARMACEUTICALS INCS — Open-market sale1.3K$78.01$103K
2026-05-15IONSIONIS PHARMACEUTICALS INCM — Option exercise1.3K$32.60$43K
2026-03-11IONSIONIS PHARMACEUTICALS INCS — Open-market sale [10b5-1]17.6K$76.34$1.34M
2026-03-11IONSIONIS PHARMACEUTICALS INCS — Open-market sale [10b5-1]16.5K$75.47$1.25M
2026-03-11IONSIONIS PHARMACEUTICALS INCM — Option exercise [10b5-1]34.1K$60.89$2.08M
2026-03-11IONSIONIS PHARMACEUTICALS INCS — Open-market sale [10b5-1]1.7K$75.58$127K
2026-03-11IONSIONIS PHARMACEUTICALS INCS — Open-market sale [10b5-1]117.6K$75.26$8.85M
2026-03-11IONSIONIS PHARMACEUTICALS INCS — Open-market sale [10b5-1]7.4K$74.11$547K
2026-03-11IONSIONIS PHARMACEUTICALS INCM — Option exercise [10b5-1]73.5K$60.89$4.48M
2026-03-11IONSIONIS PHARMACEUTICALS INCM — Option exercise [10b5-1]40.8K$60.89$2.49M
2026-03-03IONSIONIS PHARMACEUTICALS INCJ — Other acquisition / disposition484$48.87$24K

Companies — Last 90 Days

Frequently Asked Questions

Who is Monia Brett P?

Brett P. Monia is the Chief Executive Officer and Director of Ionis Pharmaceuticals, a leader in antisense technology for drug development. Under his leadership, Ionis has focused on innovative treatments for various diseases, including cardiovascular and neurological conditions.…

How many SEC Form 4 filings has Monia Brett P submitted recently?

3 primary Form 4 filings in the last 90 days, covering 2 companies.

Has Monia Brett P been buying or selling stock?

Recorded transactions: 0 open-market purchases () and 20 open-market sales ($43.06M) across all tracked filings.

Where can I see all of Monia Brett P's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

Open the live Monia Brett P profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.